# TareBio landing page growth score: 44/100

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-s26/tarebio
Source observed: 2026-10-16T13:14:41.996Z
Last checked: 2026-10-17T10:21:59.619+00:00
Indexed: 2026-10-16T16:42:57.492+00:00

---

# TareBio landing page growth score

We are Lazyweb, and this report evaluates the public landing page for [TareBio](https://tarebio.com/), whose visible value proposition is “Vaccines for any cancer or infection.” The report was updated **September 20, 2026** and gives the landing page an overall **Growth Score of 44/100**. Its weakest category is **Trust**, scored **22/100**.

## Overall ranking

Among the five compared sites, TareBio ranks fifth:

1. [Moderna — 62](https://www.lazyweb.com/growth-score/site/modernatx.com)
2. [BioNTech — 57](https://www.lazyweb.com/growth-score/site/biontech.com)
3. [Gritstone bio — 57](https://www.lazyweb.com/growth-score/site/gritstonebio.com)
4. [CureVac — 49](https://www.lazyweb.com/growth-score/site/curevac.com)
5. TareBio — 44

[Fix Trust](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Category scores

| Category | Score | Rating or focus |
| --- | ---: | --- |
| Trust | 22 | Poor |
| CTA | 32 | Poor |
| Value props | 48 | Poor |
| Mobile web | 58 | Fair |
| Information hierarchy | 62 | Fair |

## Trust — 22/100, Poor

Trust measures proof that the product is real, competent, and safe to try.

![Moderna landing-page capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/modernatx.com.jpg?v=2026-09-20T06%3A05%3A15.543%2B00%3A00)

![CureVac landing-page capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/curevac.com.jpg?v=2026-09-20T06%3A06%3A09.202%2B00%3A00)

![BioNTech landing-page capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/biontech.com.jpg?v=2026-09-20T06%3A04%3A52.394%2B00%3A00)

### Trust comparison

| Site | Trust read |
| --- | --- |
| TareBio | No visible trust signal identified. |
| BioNTech | Navigation links to “Investors,” “Clinical trials,” and “Healthcare professionals.” |
| Moderna | Headline: “Recapping Positive Phase 3 Topline Results for Intismeran Autogene Plus Pembrolizumab in Adjuvant Melanoma.” |
| CureVac | Desktop-fold acquisition statement: “CureVac is now part of the BioNTech Group (Nasdaq: BNTX).” |
| Gritstone bio | No visible trust signal identified. |

### Trust ranking

1. Moderna — 68
2. CureVac — 55
3. BioNTech — 48
4. Gritstone bio — 38
5. TareBio — 22

[Build proof section](https://www.lazyweb.com/backlog?site=tarebio.com#opt-trust-signals) — choose proof signals and receive copy and placement for a stronger trust section.

## CTA — 32/100, Poor

This category evaluates the primary call to action’s copy, size, verb, and perceived cost of clicking. TareBio’s visible contact option is **contact@tarebio.com**.

![TareBio CTA comparison capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/tarebio.com.jpg?v=2026-09-20T05%3A58%3A33.152%2B00%3A00)

### Problems found

- There is no button; there is only a mailto link.
- There is no action verb, so the link reads as a label.
- Clicking an email link feels costly.
- The link has a tiny footprint compared with the headline.

### CTA ranking

1. Moderna — 62
2. BioNTech — 58
3. Gritstone bio — 58
4. CureVac — 42
5. TareBio — 32

[Rewrite this CTA](https://www.lazyweb.com/backlog?site=tarebio.com#opt-cta-writing) — generate primary and secondary CTA options grounded in TareBio’s offer and visitor objections.

## Value props — 48/100, Poor

This category evaluates whether the title, subtitle, and hero communicate the product’s value.

### TareBio headline

- Company name: **“TareBio”**
- Subtitle: **“Vaccines for any cancer or infection.”**

### What works

- Bold, outcome-level claim.
- One line that is instantly readable.
- No buzzword filler.

### What could improve

- The large claim has no mechanism or proof.
- The headline is only the company name.
- There is no hero visual showing the science.

### Value-proposition ranking

1. BioNTech — 55
2. TareBio — 48
3. Moderna — 48
4. Gritstone bio — 48
5. CureVac — 38

## Mobile web — 58/100, Fair

This category evaluates the phone experience as a first-class citizen.

![Mobile web annotations on the TareBio mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/tarebio.com-mobile.jpg?v=2026-09-20T05%3A58%3A33.152%2B00%3A00)

The single annotated issue is **Email text link**: the only action is a small, low-contrast mailto link, and no tappable button-sized CTA exists on the page.

[View mobile fixes](https://www.lazyweb.com/backlog?site=tarebio.com#opt-mobile-web) — convert the mobile findings into a prioritized implementation checklist.

## Information hierarchy — 62/100, Fair

This category evaluates whether the design helps or inhibits the page’s intended message.

![Information hierarchy annotations on the TareBio desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/tarebio.com.jpg?v=2026-09-20T05%3A58%3A33.152%2B00%3A00)

1. **`contact@tarebio.com` link:** the only action is a small grey text link with weak contrast; it reads as metadata rather than a CTA.
2. **Orange subtitle line:** the extraordinary claim stands alone without supporting proof or a descriptor beneath it, leaving the scan path with nowhere to go.

[View layout plan](https://www.lazyweb.com/backlog?site=tarebio.com#opt-information-hierarchy) — turn these callouts into a sequenced page plan.

## Competitors

The comparison set is inferred from product, audience, and value proposition. Each score is the overall growth score shown in this report.

- [Moderna — modernatx.com — 62](https://www.lazyweb.com/growth-score/site/modernatx.com)
- [BioNTech — biontech.com — 57](https://www.lazyweb.com/growth-score/site/biontech.com)
- [Gritstone bio — gritstonebio.com — 57](https://www.lazyweb.com/growth-score/site/gritstonebio.com)
- [CureVac — curevac.com — 49](https://www.lazyweb.com/growth-score/site/curevac.com)
- TareBio — 44

## Report links

- [Back to YC S26](https://www.lazyweb.com/yc-s26)
- [TareBio website](https://tarebio.com/)
- [Trust breakdown](https://www.lazyweb.com/yc-s26/tarebio#gs-trust)
- [CTA breakdown](https://www.lazyweb.com/yc-s26/tarebio#gs-cta)
- [Value-props breakdown](https://www.lazyweb.com/yc-s26/tarebio#gs-value_props)
- [Mobile-web breakdown](https://www.lazyweb.com/yc-s26/tarebio#gs-mobile_web)
- [Information-hierarchy breakdown](https://www.lazyweb.com/yc-s26/tarebio#gs-information_hierarchy)

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Ftarebio&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-s26%2Ftarebio). Opening a form does not execute a tool.